SANTO, a company, received three important certificates for compliance with the Good Manufacturing Practice (GMP) for its production sites engaged in manufacturing of solutions for injection, infusion, and solid oral medicines, as well as a certificate for compliance of its pharmacy warehouse with the Good Distribution Practice (GDP).
These certificates provide a compelling confirmation that the quality assurance system and manufacturing conditions in SANTO meet high standards, which guarantees the quality of manufactured products.
“I am proud that the company made yet another achievement by obtaining certificates for our production sites, including the new shop for solid oral medicines and our pharmacy warehouse,” said Jiri Urbanec, General Director of SANTO. “This is certainly the result of successful teamwork. It is also a convincing evidence that we are making every effort to ensure that patients have access to high-quality and effective therapy. Today, the drugs provided by the company are used in cardiology, gastroenterology, allergology, dermatology, neurology, gynecology, urology, pediatrics, ophthalmology, pulmonology, otorhinolaryngology, and we are also manufacturing antibiotics. We love our country and care about the health of the people of Kazakhstan.”